The Claim

Progesterone and vitamin D suppress the TLR4-MyD88-NF-κB signaling pathway in monocytes isolated from women with preeclampsia, leading to a reduction in the production of downstream inflammatory cytokines in vitro.

Source: Progesterone and vitamin D downregulate the activation of the NLRP1/NLRP3 inflammasomes and TLR4-MyD88-NF-κB pathway in monocytes from pregnant women with preeclampsia.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
42score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In women with a pregnancy complication called preeclampsia, two natural substances—progesterone and vitamin D—may calm down an overactive immune response in certain blood cells, which could help reduce harmful inflammation.

See the scientific wording

Progesterone and vitamin D suppress the TLR4-MyD88-NF-κB signaling pathway in monocytes from women with preeclampsia, reducing downstream inflammatory cytokine production in vitro.

What the research says

1 study

  1. Study: Progesterone and vitamin D downregulate the activation of the NLRP1/NLRP3 inflammasomes and TLR4-MyD88-NF-κB pathway in monocytes from pregnant women with preeclampsia.

    The study found that progesterone and vitamin D calm down overactive immune cells in women with preeclampsia, reducing the signals that cause inflammation. This supports the idea that these two substances help lower harmful inflammation in the body.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.